From Nasdaq, Inc.: 2025-03-22 16:00:00

Validea’s guru fundamental report for HEALTHEQUITY INC (HQY) shows that it rates highest using the Contrarian Investor model based on David Dreman’s strategy. This strategy looks for improving fundamentals in unpopular mid- and large-cap stocks. HQY is a mid-cap growth stock in the Software & Programming industry, with a 50% rating based on fundamentals and valuation. The stock meets some of the Contrarian Investor strategy’s tests, such as current ratio and total debt/equity. David Dreman’s investment strategies have a strong track record, with his Kemper-Dreman High Return Fund ranking as one of the best-performing mutual funds.



Read more at Nasdaq, Inc.: HQY Quantitative Stock Analysis | Nasdaq